Catastrophic cryofibrinogenaemia associated with chronic lymphocytic leukaemia and salvage therapy using plasmapheresis and cyclophosphamide
J Eur Acad Dermatol Venereol
.
2017 Jan;31(1):e38-e39.
doi: 10.1111/jdv.13628.
Epub 2016 Jun 14.
Authors
M AlGain
1
2
3
,
R Damade
4
,
F Aucouturier
2
5
,
J Rivet
2
6
,
M Jachiet
1
2
,
M Malphettes
2
7
8
,
G Hickman
1
2
,
R Szalat
2
7
,
A Saussine
1
2
,
A de Masson
1
2
,
A Petit
1
2
,
M Rybojad
1
2
8
,
M Bagot
1
2
,
B Arnulf
2
7
8
,
J D Bouaziz
1
2
8
Affiliations
1
Department of Dermatology, Saint-Louis Hospital, Paris, France.
2
Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France.
3
King Abdulaziz University, Jeddah, Saudia Arabia.
4
Department of Internal Medicine, Hospital Louis Pasteur, Chartres, France.
5
Department of Biological Immunology, Saint-Louis Hospital, Paris, France.
6
Department of Pathology, Saint-Louis Hospital, Paris, France.
7
Department of Clinical Immunology, Saint-Louis Hospital, Paris, France.
8
Groupe d'Etude des Dermatoses associées à une Immunoglobuline Monoclonale, Paris, France.
PMID:
27297832
DOI:
10.1111/jdv.13628
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Aged
Cryoglobulinemia / etiology*
Cryoglobulinemia / therapy
Cyclophosphamide / therapeutic use*
Female
Humans
Leukemia, Lymphoid / congenital*
Plasmapheresis*
Salvage Therapy / methods*
Substances
Cyclophosphamide
Supplementary concepts
Cryofibrinogenemia